A multi-hospital, clinician-initiated bacterial genomics program to investigate treatment failure in severe<i>Staphylococcus aureus</i>infections

Abstract Bacterial genomics is increasingly used for infectious diseases surveillance, outbreak control and prediction of antibiotic resistance. With expanding availability of rapid whole-genome sequencing, bacterial genomics data could become a valuable tool for clinicians managing bacterial infections, driving precision medicine strategies. Here, we present a novel clinician-driven bacterial genomics framework that applies within-patient evolutionary analysis to identify in real-time microbial genetic changes that have an impact on the outcome of severeStaphylococcus aureusinfections, a strategy that is increasingly used in cancer genomics. Our approach uses a combination of bacterial genomics and novel microbiological testing to identify and track bacterial adaptive mutations that underlie antibiotic treatment failure. We show real-life examples of the impact of our approach and propose a roadmap for the use of bacterial genomics to advance the management of severe bacterial infections..

Medienart:

Preprint

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

bioRxiv.org - (2023) vom: 27. Okt. Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Beteiligte Personen:

Giulieri, Stefano G. [VerfasserIn]
Leroi, Marcel [VerfasserIn]
Daniel, Diane [VerfasserIn]
Chean, Roy [VerfasserIn]
Bond, Katherine [VerfasserIn]
Walker, Harry [VerfasserIn]
Holmes, Natasha E. [VerfasserIn]
Mothobi, Nomvuyo [VerfasserIn]
Alexander, Adrian [VerfasserIn]
Jenney, Adam [VerfasserIn]
Beckett, Carolyn [VerfasserIn]
Mahony, Andrew [VerfasserIn]
Stevens, Kerrie [VerfasserIn]
Sherry, Norelle L. [VerfasserIn]
Howden, Benjamin P. [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

570
Biology

doi:

10.1101/2023.10.23.23297384

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

XBI041308530